News and Press Releases

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

OKN4395 is the first Owkin development program to leverage K1.0, Owkin’s AI-powered Operating System, from asset selection to clinical development optimization This asset is a highly selective triple inhibitor of...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 30, 2025

14/16 Bd Poissonnière, 75009 Paris

Clinigen Announces Strategic Partnership with Tepsivo

Expanding Client Choice with AI-Powered Pharmacovigilance Solutions 27 January 2025 -- London, UK -- Clinigen, the global specialist pharmaceutical services company, today announced a strategic partnership with Tepsivo, a pioneering...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: January 27, 2025

25 Bedford Square Bloomsbury London WC1B 3HH

Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring

Study published in JMIR validates the feasibility, use and safety of a digital platform for remote, routine monitoring of blood pressure and medication in hypertension patients Findings support the use...

Category: Biotechnology, Other, Pharmaceutical
Posted: December 17, 2024

Babraham Research Campus Cambridge CB22 3AT United Kingdom

Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics

Science-driven collaboration ameliorates neurological assessments and endpoint data quality, enhances the rater and patient experience, and integrates Medidata App innovations with Cogstate capabilities 29 October 2024 -- New York, US...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other
Posted: October 29, 2024

350 Hudson Street New York, NY 10014 USA

Owkin announces partnership with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer

2 October 2024 -- Paris, France -- Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to announce a...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 2, 2024

14/16 Bd Poissonnière, 75009 Paris

Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors

Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones 11 Sep 2024 -- London, UK -- Closed Loop Medicine Ltd.,...

Category: Biotechnology, Other, Pharmaceutical
Posted: September 11, 2024

Babraham Research Campus Cambridge CB22 3AT United Kingdom

AI can detect lung nodules that could lead to lung cancer nearly 3 years before symptoms and actual diagnosis, study finds

Evidence presented at 2024 World Conference on Lung Cancer highlights chest X-ray AI’s potential to detect lung nodules early and expedite patient care 10 September 2024 -- New York, US...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 10, 2024

C/O RODl & Partner Legal Limited, 170 Edmund Street, Birmingham, United Kingdom B3 2HB 74909

Veridix AI, part of Emmes Group, Announces New Protocol Digitization Capabilities

Protocol digitization extracts structured data elements from unstructured text Automates database study builds, reducing build timelines by up to 30% Deployed within 40 study builds across Emmes CRO’s portfolio of...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: August 14, 2024

401 N. Washington Street Suites 700 Rockville, MARYLAND 20850

In a First for Pharma, Citeline SmartSolutions Take AI to New Levels, Optimizing Clinical Trial Planning and Site Selection

Protocol SmartDesign and Investigator SmartSelect bring treatments to patients faster by accelerating clinical trial development 13 August 2024 -- London, UK -- Citeline, a leader in intelligence solutions for the...

Category: Clinical Trials, Pharmaceutical
Posted: August 13, 2024

SSI Strategy and Metalmind Partner for Enterprise AI Solutions

23 July 2024 , New Jersey US, Kista, Sweden, – SSI Strategy LLC, a global leader in strategic consulting for life sciences, is pleased to announce a partnership with MPS...

Category: Biotechnology
Posted: July 30, 2024

9 Campus Drive ,1st floor Parsippany, NJ 07054, US

Avallano releases ProtocolCopilot: Powering Clinical Research with AI-driven Protocol Assistance

16 July 2024 -- South Carolina, US -- Avallano is launching ProtocolCopilot, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: July 16, 2024

Greenville, South Carolina, 29609

Elemental Machines Expands European Presence and Enhances AI-Predicted Health Score

27 June 2024 -- Florence, Italy -- Elemental Machines, a leader in smart lab and manufacturing connectivity solutions, is pleased to announce they are consolidating their position in the EU...

Category: BioManufacturing, Pharmaceutical
Posted: June 27, 2024

Viale Giacomo Matteotti, 15 50121 Firenze FI, Italy

WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research

26 June 2024 -- New Jersey, US -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, and the Multi-Regional Clinical Trials Center of Brigham...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: June 26, 2024

212 Carnegie Center, Suite 301, Princeton, NJ 08540, USA

Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation

26 June 2024 -- South Carolina, US -- Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A Ibara PharmD, as chief strategy officer (CSO). Dr Ibara...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 26, 2024

Greenville, South Carolina, 29609

Basecamp Research launches ZymCTRL a world-first, open source, generative AI tool that designs enzymes for more sustainable industrial processes. ZymCTRL is the world’s first open-source, text-based enzyme generation model and can be used across multiple industries, including therapeutics and sustainability initiatives.

AI model able to produce sequences that produced functional enzymes with desirable characteristicsfor industrial applications. Basecamp Research field scientists collect samples during an expedition to Costa Rica on July 29,...

Category: BioManufacturing, Drug Delivery, Drug Discovery, Other
Posted: June 18, 2024

Unit 315, Clerkenwell Workshops 27 Clerkenwell Close London, EC1R 0AT